Here’s what you should know:
1. Valeant has an 11-member board, 10 of those members are independent.
2. Mr. Paulson said in a release that he fully supports Valeant’s attempts to invest in its core products while, selling off non-core assets to de-lever the company.
3. Valeant CEO and President Joseph C. Papa said in a release, “We are pleased to welcome John to Valeant’s board of directors. With his significant business and financial expertise, John will be a strong addition to the board. His experience will be especially valuable as we continue to execute on our transformational strategy to turnaround Valeant.”
More articles on gastroenterology:
GI leader to know: Dr. David Schwartz of Vermont Gastroenterology
Exact Sciences pockets $238M from secondary stock sale — 3 key notes
Clarivate Analytics ranks AGA’s flagship magazine highest of 79 journals
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
